Gross Profit: Revenues from operations less the associated costs.
Novartis AG (NVS) had Gross Profit of $10.25B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$13.86B |
|
$2.41B |
|
$3.61B |
|
|
Gross Profit |
$10.25B |
$10.24B |
|
$3.62B |
|
$-398.00M |
|
$3.22B |
|
$3.22B |
|
$2.40B |
|
$2.40B |
|
$2.40B |
|
$2.40B |
|
$3.62B |
|
$5.15B |
|
1.94B |
|
1.96B |
|
$1.27 |
|
$1.25 |
|
| Balance Sheet Financials | |
$30.46B |
|
$10.78B |
|
$80.49B |
|
$110.95B |
|
$27.28B |
|
$27.93B |
|
$37.12B |
|
$64.40B |
|
$46.55B |
|
$-8.43B |
|
$46.55B |
|
1.91B |
|
| Cash Flow Statement Financials | |
$19.14B |
|
$-4.88B |
|
$-14.87B |
|
$11.46B |
|
$11.44B |
|
$-24.00M |
|
$1.10B |
|
$-7.82B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
0.38 |
|
0.72 |
|
73.95% |
|
26.09% |
|
26.09% |
|
-- |
|
23.22% |
|
17.38% |
|
$17.61B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.58 |
|
1.52 |
|
59.36 |
|
5.16% |
|
-28.52% |
|
2.17% |
|
3.23% |
|
$24.39 |
|
$9.01 |
|
$9.79 |
|